We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Focused Ultrasound May Benefit Patients with Epilepsy

By HospiMedica International staff writers
Posted on 17 Nov 2021
Image: Focused ultrasound being delivered using neuronavigation and EEG monitoring (Photo courtesy of Hsiang-Yu Yu/ VGHTPE)
Image: Focused ultrasound being delivered using neuronavigation and EEG monitoring (Photo courtesy of Hsiang-Yu Yu/ VGHTPE)
A new study suggests that focused ultrasound (FUS) of the brain may benefit patients with drug-resistant epilepsy (DRE).

Researchers at National Yang Ming Chiao Tung University (NYCU; Taipei, Taiwan), Taipei Veterans General Hospital (Taiwan), and other institutions conducted a study in six DRE patients who were scheduled to undergo stereo-electroencephalography (SEEG) for localization of the seizure onset zone (SOZ), providing a window of opportunity to investigate the neuromodulatory effects of FUS. Simultaneous SEEG recordings were obtained during sonication and for three days after treatment to monitor seizures, interictal epileptiform discharges, and adverse events.

The results revealed a decrease in seizure frequency in two patients within the three-day follow-up, with significant changes in spectral power of SEEG noted at the targeted electrodes during FUS; one patient showed an increase in the frequency of subclinical seizures. Magnetic resonance imaging (MRI) revealed neither lesion nor brain edema. One patient reported subjective scalp heating during FUS, and one patient developed transient naming and memory impairment that resolved within three weeks. The study was published on November 2, 2021, in Epilepsia.

“Neuromodulation is an alternative treatment for drug-resistant epilepsy. Compared with the present modalities used in neuromodulation for epilepsy, focused ultrasound can access deeper brain regions and focus on the main target of the epileptic network in a relatively less invasive approach,” said senior author Hsiang-Yu Yu, PhD, of VGHTPE and the NYCU Brain Research Center. “It gives new hope and sheds new light for patients with drug-resistant epilepsy.”

Focused ultrasound is based on nonlinear acoustic mathematical optimization methods to analyze and simulate the propagation of sound in material. The information is then used to enhance the shape of an acoustic lens in such a way that that ultrasound pressure is focused precisely on the location of the tissue to be treated, while the surrounding tissue retains as little damage as possible.

Related Links:
National Yang Ming Chiao Tung University
Taipei Veterans General Hospital


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Patient Preoperative Skin Preparation
BD ChloraPrep
New
Resorbable Bovine Collagen Membrane
GenDerm

Channels

Critical Care

view channel
Image: The nasal spray is created using the ‘Nano-in-Micron’ technology platform. The micron-sized powder is inhaled and travels along the nose-to-brain pathway, bypassing the blood-brain barrier to deliver the drug directly to the brain (Photo courtesy of The University of Hong Kong

New Nasal Spray Enables Prehospital Neuroprotection in Ischemic Stroke

Ischemic stroke, caused by arterial occlusion in the brain, requires time‑critical intervention to limit neuronal loss. Many patients arrive outside the narrow window for thrombolysis or thrombectomy,... Read more

Surgical Techniques

view channel
Image: MUSA-3 is designed to assist surgeons during open super‑microsurgical procedures by downscaling and stabilizing hand movements (Photo courtesy of Microsure)

Robotic Microsurgery System Gains CE Mark for Clinical Use in Europe

Microsure (Eindhoven, The Netherlands) announced on May 7, 2026 that its MUSA-3 system received CE mark approval, enabling clinical use in Europe. The milestone marks the company’s transition from product... Read more